Horizons ami trial, harmonizing outcomes with revascularization and stents in acute myocardial infarction. We sought to identify clinical, electrocardiographic ecg, and angiographic characteristics that are predictive of 3. However, the incidence of symptomatic chf after primary percutaneous coronary intervention pci for stsegment elevation myocardial infarction stemi has rarely been fully reported. Coronary reperfusion and clinical outcomes after thrombus. In brief, in the replace2 trial, 6,010 patients undergoing elective or. Horizons ami harmonizing outcomes with revascularization and stents in acute myocardial. Paclitaxeleluting stents versus baremetal stents in acute. Horizons ami was a dual arm factorial randomized trial in pts with stemi. Correlation of admission heart rate with angiographic and.
Oct 01, 20 read coronary reperfusion and clinical outcomes after thrombus aspiration during primary percutaneous coronary intervention. Ami trial, catheterization and cardiovascular interventions on deepdyve, the largest online rental service for scholarly research with thousands of academic publications available at your fingertips. View enhanced pdf access article on wiley online library html view download pdf for offline viewing. Methods in the horizons ami harmonizing outcomes with revascularization and stents in acute myocardial infarction trial, 668 of the 3,602 stemi patients enrolled 18. Bivalirudin enhances longterm survival in patients with st elevation myocardial infarction undergoing angioplasty. The two primary end points of the study were major bleeding and combined adverse clinical events. Article information, pdf download for the prognostic importance of left. The harmonizing outcomes with revascularization and stents in acute myocardial infarction horizons ami trial was a prospective, openlabel, multicenter, controlled trial involving patients with. The horizonsami trial was an international, multicenter, prospective, openlabel, randomized study designed to examine the safety and efficacy of bivalirudin monotherapy compared with ufh plus routine gpis, and the paclitaxeleluting taxus stent compared with a bare metal express 2 stent in patients with stemi undergoing primary pci. Publications home of jama and the specialty journals of the. Incidence and angiographic characteristics of patients with apical ballooning syndrome takotsubostress cardiomyopathy in the horizons.
In brief, in the acuity trial,819 patients with moderate and highrisk acs unstable. Stemi from the harmonizing outcomes with revascularization and stents in acute myocardial infarction horizons. Horizonsami trial data shows 43 percent mortality reduction. Of patients in the angiomax arm, the majority 93 percent received angiomax monotherapy. While playing, you will encounter a lot of people called navigators, whom you can recruit for you team, many weapon and armour types, ship guns, different cities in the distant corners of the world, and, finally, more than 20 historical types of ships. The horizons ami trial compared angiomax to heparin plus a platelet gpi in 3,602 patients presenting with the most severe form of heart attack, known as stelevation myocardial infarction stemi undergoing a primary pci strategy. Dynamic nature of nonculprit coronary artery lesion morphology in stemi a serial ivus analysis from the horizonsami trial zhijing zhao, md, bernhard witzenbichler, md, gary s. A total of 1089 stemi patients enrolled in the horizons ami trial had baseline bnp levels measured in the emergency room as part of the study protocol. We therefore examined the early and late incidence, predictors, and implications of chf in the largescale, prospective, randomized horizons ami trial. The landmark horizons ami trial, sponsored by crf, is expected to significantly impact the way that patients are treated. Bleeding outcomes after routine transradial primary.
The inclusion and exclusion criteria are included as well as the primary and secondary endpoints. Incidence and predictors of heart failure following. Bivalirudin treatment was associated with improved eventfree survival at 30 days and reduced rates of major bleeding. Final 3year results from a multicentre, randomised controlled trial lancet. The horizonsami trial was a prospective, open label, randomized. Horizonsami harmonizing outcomes with revascularization and stents in acute myocardial infarction trial have been previously published. Dynamic nature of nonculprit coronary artery lesion.
The harmonizing outcomes with revascularization and stents in acute myocardial infarction horizonsami trial was a. A risk score to predict bleeding in patients with acute coronary. Prognostic impact of staged versus onetime multivessel. Ami the harmonizing outcomes with revascularization and stents in acute myocardial infarction trial. The horizonsami harmonizing outcomes with revascularization.
Stone md columbia university medical center cardiovascular research foundation. Death from noncardiac causes included bleedingrelated death. The harmonizing outcomes with revascularization and stents in. As part of a formal ivus substudy, virtual histology vhivus was performed in 166 culprit lesions in 158 pts either pre andor post stent implantation.
Role of clopidogrel loading dose in patients with st. Bivalirudin enhances longterm survival in patients with stelevation myocardial infarction undergoing angioplasty. Segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Harmonizing outcomes with revascularization and stents in. Whether the dose of aspirin affects longterm patient outcomes is unknown. Bivalirudin during primary pci in acute myocardial infarction nejm. Patients were categorized into a single pci strategy n 275 versus staged pci n 393. Horizonsami trial, harmonizing outcomes with revascularization and stents in acute myocardial infarction. A read is counted each time someone views a publication summary such as the title, abstract, and list of authors, clicks on a figure, or views or downloads the fulltext.
Role of clopidogrel loading dose in patients with stsegment. Ami trial an analysis from a multicenter, international study of st. In the horizons ami trial, 3,602 patients with ami undergoing primary pci were prospectively randomized to unfractionated heparin plus routine use of glycoprotein gp iibiiia inhibitors versus the direct thrombin inhibitor bivalirudin plus provisional use of gp iibiiia inhibitors reserved for predefined thrombotic complications. The design, inclusion and exclusion criteria, and results of the horizonsami trial have been previously published. Effect of short procedural duration with bivalirudin on increased. The 12month results of horizonsami oct 3, p 11491 show that, in patients with stsegmentelevation myocardial infarction stemi undergoing primary percutaneous coronary intervention pci, anticoagulation with bivalirudin reduced net adverse clinical events and major bleeding at 1 year compared with heparin plus a glycoprotein iibiiia inhibitor. Horizons ami trial, 291 patients were excluded from the present study, including 143 patients treated with thienopyridines before the randomization, pafigure 1 flow chart of the present study enrollment and followup of the patients pts in the trial. As it was mentioned above, uncharted waters is a very complex and highly sophisticated game.
Acuity and horizonsami trials have been pub lished 11,1619. In the harmonizing outcomes with revascularization and stents in acute myocardial infarction horizonsami randomized clinical trial. Bivalirudin for primary percutaneous coronary intervention in. This article provides an update on key modalities used to determine infarct size, and recent advances in interventions used to reduce infarct size.
The purpose of this study was to determine whether, in patients with. Infarct size reduction in acute myocardial infarction heart. Heparin plus a glycoprotein iibiiia inhibitor versus bivalirudin monotherapy and paclitaxeleluting stents versus baremetal stents in acute myocardial infarction horizonsami. A large prospective randomized trial of des vs bms in patients with stemi gregg w. Heparin plus a glycoprotein iibiiia inhibitor versus bivalirudin monotherapy and paclitaxeleluting stents versus baremetal stents in acute myocardial infarction horizons ami. Intracoronary abciximab and aspiration thrombectomy in. Impact of bleeding on mortality after percutaneous coronary. Ami trial, catheterization and cardiovascular interventions on deepdyve, the largest online rental service for scholarly research with thousands of academic publications available at your. Infarct size following stemi is a determinant of heart failure and death. Predictors of suboptimal timi flow after primary angioplasty for acute myocardial infarction. Replace2 trial in stable and unstable ischemic syndromes, the acuity trial in unstable angina and nonstemi, and horizonsami trial in patients with stemi. The acuity and horizonsami trial designs and results have previously been described. In the horizons ami trial, patients with acute stsegment elevation myocardial infarction stemi undergoing percutaneous coronary intervention pci who were treated with the thrombin inhibitor bivalirudin had substantially lower 30day rates of major haemorrhagic complications and net adverse clinical events than did patients assigned to heparin plus a glycoprotein iibiiia inhibitor gpi. Methods we compared 3year outcomes in patients who were prescribed highdose 200 mg daily versus lowdose.
The landmark horizonsami trial, sponsored by crf, is expected to significantly impact the way that patients are treated. The horizons ami trial was an international, multicenter, prospective, openlabel, randomized study designed to examine the safety and efficacy of bivalirudin monotherapy compared with ufh plus routine gpis, and the paclitaxeleluting taxus stent compared with a bare metal express 2 stent in patients with stemi undergoing primary pci. Cardiovascular disease is the leading cause of death in the us. Quantitative angiography was performed by a core laboratory to identify the frequency and severity of coronary artery disease. Home journal of the american heart association vol.
We assessed allcause and cardiac mortality, nonfatal mi, tvr, stent thrombosis, ischemic stroke, noncabg related major bleeding and net adverse clinical events. Fibroatheromas fa were lesions with 10% confluent necrotic core nc. Incidence and angiographic characteristics of patients with. Aug 07, 2012 horizons ami harmonizing outcomes withrevascularization and stents in acute myocardial infarctiongw stone columbia university medical center cardiovascular research foundation, nytct 2007 meeting population. Tct200 correlation of admission heart rate with angiographic and clinical outcomes by culprit coronary artery in patients with stemi undergoing primary pci. Horizons ami the harmonizing outcomes with revascularization and stents in acute myocardial infarction trial. Twoyear data from the trial will also be presented as a late breaking.
More recently, the horizons ami randomized, openlabel, multicenter trial has compared the efficacy and safety of bivalirudin alone versus ufh plus a gpi in 3602 patients with stsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Paclitaxeleluting stents versus baremetal stents in. Jan 30, 2010 the 12month results of horizons ami oct 3, p 11491 show that, in patients with stsegmentelevation myocardial infarction stemi undergoing primary percutaneous coronary intervention pci, anticoagulation with bivalirudin reduced net adverse clinical events and major bleeding at 1 year compared with heparin plus a glycoprotein iibiiia inhibitor. The harmonizing outcomes with revascularization and stents in acute myocardial infarction horizonsami trial was a prospective, openlabel, multicenter, controlled trial involving patients with.
Pdf predictors of suboptimal timi flow after primary. In addition, acute myocardial infarction mi is a predictor of thrombotic stent complications occurring late after drugeluting stent implantation, particularly in the presence of a high thrombus burden, raising concerns regarding the balance of risks and benefits of these devices in this clinical setting. Request pdf on nov 1, 2008, luigi oltrona visconti and others published the horizonsami trial find, read and cite all the research you need on researchgate. Ischemic outcomes after coronary intervention of calcified vessels. Sep 01, 20 read bleeding outcomes after routine transradial primary angioplasty for acute myocardial infarction using eptifibatide and unfractionated heparin. Death from cardiac causes was defined as death due to acute myocardial infarction, cardiac perforation or pericardial tamponade, arrhythmia or conduction abnormality, stroke, procedural complications, or any death for which a cardiac cause could not be ruled out. Stsegment elevation myocardial infarction stemi is typically caused by acute thrombotic occlusion of an epicardial coronary artery, resulting in a wave front of myonecrosis from the subendocardium to the subepicardium, which is complete within several hours1 although this time course can be substantially delayed by intermittent flow in the infarct artery and collateral vessels to the. Longterm followup, in terms of deathreinfarction, of the previously described trials together with several important rcts which are underway, such as horizons ami 3400 ami patients randomized to paclitaxelemitting stents pes or bms and cezar 352 ami patients randomized to pes or sirolimuseluting stents ses, will be necessary to. In the horizons ami trial, monotherapy with bivalirudin was compared with the combination of heparin and a gpi in a large population of patients with stemi who underwent primary pci. Incidence and angiographic characteristics of patients. The design and principal results of each trial have been published previously 1519. Correlation of admission heart rate with angiographic and clinical outcomes in patients with right coronary artery stsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
887 53 324 307 1254 1562 420 1616 1490 1087 923 1082 1387 1412 499 1111 1559 611 1106 1545 771 750 1269 227 23 105 777 699 1296 1619 487 540 31 18 784 706 365 514 1072 949 1094 342 661